$111.11
-1.18 (-1.05%)
At Close: Jul 13, 2026
Revvity (RVTY) Launches Single Solution for Drug Development
01:18pm, Tuesday, 13'th Jun 2023
Revvity (RVTY) Signals Software suite integrates streamlining data, global monitoring and customizable workflows and covers the entire Make-Test-Decide lifecycle, which can be centrally managed.
Revvity (RVTY) Launches New System for Autoimmune Diagnostics
01:45pm, Tuesday, 06'th Jun 2023
Revvity's (RVTY) EUROIMMUN launches UNIQO 160, a new automated system for autoimmune disease diagnostics using indirect immunofluorescence test.
Sign In
Buy RVTY